Cargando…
EIF5A2 controls ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition via the TGFβ pathway
BACKGROUND: Epithelial to mesenchymal transition (EMT) contributes to tumor metastasis and chemoresistance. Eukaryotic initiation factor 5A2 (EIF5A2) is highly expressed in a variety of human cancers but rarely expressed in normal tissues. While EIF5A2 has oncogenic activity in several cancers and c...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025533/ https://www.ncbi.nlm.nih.gov/pubmed/33827661 http://dx.doi.org/10.1186/s13578-021-00578-5 |
_version_ | 1783675514744995840 |
---|---|
author | Zhao, Guannan Zhang, Wenjing Dong, Peixin Watari, Hidemichi Guo, Yuqi Pfeffer, Lawrence M. Tigyi, Gabor Yue, Junming |
author_facet | Zhao, Guannan Zhang, Wenjing Dong, Peixin Watari, Hidemichi Guo, Yuqi Pfeffer, Lawrence M. Tigyi, Gabor Yue, Junming |
author_sort | Zhao, Guannan |
collection | PubMed |
description | BACKGROUND: Epithelial to mesenchymal transition (EMT) contributes to tumor metastasis and chemoresistance. Eukaryotic initiation factor 5A2 (EIF5A2) is highly expressed in a variety of human cancers but rarely expressed in normal tissues. While EIF5A2 has oncogenic activity in several cancers and contributes to tumor metastasis, its role in ovarian cancer is unknown. In this study, we investigate whether EIF5A2 contributes to ovarian tumor metastasis by promoting EMT. METHODS: To investigate the role of EIF5A2, we knocked out (KO) EIF5A2 using lentiviral CRISPR/Cas9 nickase in high invasive SKOV3 and OVCAR8 cells and overexpressed EIF5A2 in low invasive OVCAR3 cells using lentiviral vector. Cell proliferation, migration and invasion was examined in vitro ovarian cancer cells and tumor metastasis was evaluated in vivo using orthotopic ovarian cancer mouse models. RESULTS: Here we report that EIF5A2 is highly expressed in ovarian cancers and associated with patient poor survival. Lentiviral CRISPR/Cas9 nickase vector mediated knockout (KO) of EIF5A2 inhibits epithelial to mesenchymal transition (EMT) in SKOV3 and OVCAR8 ovarian cancer cells that express high levels of EIF5A2. In contrast, overexpression of EIF5A2 promotes EMT in OVCAR3 epithelial adenocarcinoma cells that express relatively low EIF5A2 levels. KO of EIF5A2 in SKOV3 and OVCAR8 cells inhibits ovarian cancer cell migration and invasion, while its overexpression promotes cell migration and invasion in OVCAR3 adenocarcinoma cells. We further demonstrate that EIF5A2 promotes EMT by activating the TGFβ pathway and KO of EIF5A2 inhibits ovarian tumor growth and metastasis in orthotopic ovarian cancer mouse models. CONCLUSION: Our results indicate that EIF5A2 is an important controller of ovarian tumor growth and metastasis by promoting EMT and activating the TGFβ pathway. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13578-021-00578-5. |
format | Online Article Text |
id | pubmed-8025533 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-80255332021-04-08 EIF5A2 controls ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition via the TGFβ pathway Zhao, Guannan Zhang, Wenjing Dong, Peixin Watari, Hidemichi Guo, Yuqi Pfeffer, Lawrence M. Tigyi, Gabor Yue, Junming Cell Biosci Research BACKGROUND: Epithelial to mesenchymal transition (EMT) contributes to tumor metastasis and chemoresistance. Eukaryotic initiation factor 5A2 (EIF5A2) is highly expressed in a variety of human cancers but rarely expressed in normal tissues. While EIF5A2 has oncogenic activity in several cancers and contributes to tumor metastasis, its role in ovarian cancer is unknown. In this study, we investigate whether EIF5A2 contributes to ovarian tumor metastasis by promoting EMT. METHODS: To investigate the role of EIF5A2, we knocked out (KO) EIF5A2 using lentiviral CRISPR/Cas9 nickase in high invasive SKOV3 and OVCAR8 cells and overexpressed EIF5A2 in low invasive OVCAR3 cells using lentiviral vector. Cell proliferation, migration and invasion was examined in vitro ovarian cancer cells and tumor metastasis was evaluated in vivo using orthotopic ovarian cancer mouse models. RESULTS: Here we report that EIF5A2 is highly expressed in ovarian cancers and associated with patient poor survival. Lentiviral CRISPR/Cas9 nickase vector mediated knockout (KO) of EIF5A2 inhibits epithelial to mesenchymal transition (EMT) in SKOV3 and OVCAR8 ovarian cancer cells that express high levels of EIF5A2. In contrast, overexpression of EIF5A2 promotes EMT in OVCAR3 epithelial adenocarcinoma cells that express relatively low EIF5A2 levels. KO of EIF5A2 in SKOV3 and OVCAR8 cells inhibits ovarian cancer cell migration and invasion, while its overexpression promotes cell migration and invasion in OVCAR3 adenocarcinoma cells. We further demonstrate that EIF5A2 promotes EMT by activating the TGFβ pathway and KO of EIF5A2 inhibits ovarian tumor growth and metastasis in orthotopic ovarian cancer mouse models. CONCLUSION: Our results indicate that EIF5A2 is an important controller of ovarian tumor growth and metastasis by promoting EMT and activating the TGFβ pathway. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13578-021-00578-5. BioMed Central 2021-04-07 /pmc/articles/PMC8025533/ /pubmed/33827661 http://dx.doi.org/10.1186/s13578-021-00578-5 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Zhao, Guannan Zhang, Wenjing Dong, Peixin Watari, Hidemichi Guo, Yuqi Pfeffer, Lawrence M. Tigyi, Gabor Yue, Junming EIF5A2 controls ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition via the TGFβ pathway |
title | EIF5A2 controls ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition via the TGFβ pathway |
title_full | EIF5A2 controls ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition via the TGFβ pathway |
title_fullStr | EIF5A2 controls ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition via the TGFβ pathway |
title_full_unstemmed | EIF5A2 controls ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition via the TGFβ pathway |
title_short | EIF5A2 controls ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition via the TGFβ pathway |
title_sort | eif5a2 controls ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition via the tgfβ pathway |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025533/ https://www.ncbi.nlm.nih.gov/pubmed/33827661 http://dx.doi.org/10.1186/s13578-021-00578-5 |
work_keys_str_mv | AT zhaoguannan eif5a2controlsovariantumorgrowthandmetastasisbypromotingepithelialtomesenchymaltransitionviathetgfbpathway AT zhangwenjing eif5a2controlsovariantumorgrowthandmetastasisbypromotingepithelialtomesenchymaltransitionviathetgfbpathway AT dongpeixin eif5a2controlsovariantumorgrowthandmetastasisbypromotingepithelialtomesenchymaltransitionviathetgfbpathway AT watarihidemichi eif5a2controlsovariantumorgrowthandmetastasisbypromotingepithelialtomesenchymaltransitionviathetgfbpathway AT guoyuqi eif5a2controlsovariantumorgrowthandmetastasisbypromotingepithelialtomesenchymaltransitionviathetgfbpathway AT pfefferlawrencem eif5a2controlsovariantumorgrowthandmetastasisbypromotingepithelialtomesenchymaltransitionviathetgfbpathway AT tigyigabor eif5a2controlsovariantumorgrowthandmetastasisbypromotingepithelialtomesenchymaltransitionviathetgfbpathway AT yuejunming eif5a2controlsovariantumorgrowthandmetastasisbypromotingepithelialtomesenchymaltransitionviathetgfbpathway |